Publications by authors named "Chang-shan Liu"
Efficacy of Huaiqihuang granules as adjuvant therapy for bronchial asthma in children: a real-world study.
Zhongguo Dang Dai Er Ke Za Zhi
September 2021
Objectives: To study the efficacy of Huaiqihuang granules as adjuvant therapy for bronchial asthma in children.
Methods: A multicenter, prospective, and registered real-world study was performed for the children, aged 2-5 years, who had a confirmed diagnosis of bronchial asthma in the outpatient service of 21 hospitals in China. Among these children, the children treated with medications for long-term asthma control (inhaled corticosteroid and/or leukotriene receptor antagonist) without Huaiqihuang granules were enrolled as the control treatment group, and those treated with medications for long-term asthma control combined with Huaiqihuang granules were enrolled as the combined treatment group.
Background: Herpangina is a common infectious disease in childhood caused by an enterovirus. This consensus is aiming to standardize and improve herpangina prevention and clinical diagnosis.
Methods: The Subspecialty Group of Infectious Diseases, the Society of Pediatric, Chinese Medical Association and Nation Medical Quality Control Center for Infectious Diseases gathered 20 experts to develop the consensus, who are specialized in diagnosis and treatment of herpangina.
[Association between serum allergens and asthma in children].
Zhongguo Dang Dai Er Ke Za Zhi
August 2015
Objective: To study the association between serum-specific immunoglobulin E (sIgE) allergens and asthma in children.
Methods: The serum sIgE allergens were determined using Western blot in 2239 children aged 1-14 years, consisting of 1415 children with asthma alone and 824 children with non-allergic diseases between December 2004 and April 2013. The case-control models of asthma alone and non-allergic diseases were established.
Article Synopsis
- Asthma is a chronic inflammatory disease affecting the airways, and a study was conducted to examine the effects of low-level laser therapy (LLLT) on allergic asthma in rats, comparing it to the glucocorticoid budesonide.
- The research found that LLLT improved inflammation and reduced airway damage in asthmatic rats, decreasing harmful cell counts and adjusting the immune response, specifically regulating the Th1/Th2 balance.
- LLLT demonstrated similar benefits to budesonide, suggesting it could serve as an alternative treatment for asthma, potentially minimizing some side effects associated with glucocorticoids.